Press Tag: Milo Biotechnology

Nationwide Children’s spinoff raises funds for muscular dystrophy gene therapy trials from Rev1, JumpStart
Columbus Business First
Milo Biotechnology Announces FDA Orphan Drug Designation for Treatment of Inclusion Body Myositis
Milo Biotechnology Raises Funding from JumpStart and Rev1 Ventures
JumpStart Inc. and Rev1 Ventures Announce Investment in Milo Biotechnology
JumpStart Inc. and Rev1 Ventures Announce Investment in Milo Biotechnology
Rev1 Ventures and Nationwide Children’s Hospital Launch New Fund to Support Healthcare Innovators
Little Milo Wrestles For Gene Therapy Spotlight
Nationwide Children’s gene therapy lands TechColumbus investment (Milo Biotechnology)
Columbus Business First